ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2025 ANS Winter Conference & Expo
November 9–12, 2025
Washington, DC|Washington Hilton
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Sep 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
October 2025
Nuclear Technology
September 2025
Fusion Science and Technology
Latest News
ANS and the U.K.’s NI announce reciprocal membership agreement
With President Trump on a state visit to the U.K., in part to sign a landmark new agreement on U.S.-U.K. nuclear collaboration, a flurry of transatlantic partnerships and deals bridging the countries’ nuclear sectors have been announced.
The American Nuclear Society is taking an active role in this bridge-building by forming a reciprocal membership agreement with the U.K.’s Nuclear Institute.
D. Galeriu, H. Takeda, A. Melintescu, A. Trivedi
Fusion Science and Technology | Volume 48 | Number 1 | July-August 2005 | Pages 795-798
Technical Paper | Tritium Science and Technology - Biology, Health, and Radiation | doi.org/10.13182/FST05-A1040
Articles are hosted by Taylor and Francis Online.
In the frame of current revision of human dosimetry of 14C and tritium, undertaken by the International Commission of Radiological Protection, we propose a novel approach based on energy metabolism and a simple biokinetic model for the dynamics of dietary intake (organic 14C, tritiated water and Organically Bound Tritium-OBT). The model predicts increased doses for HTO and OBT comparing to ICRP recommendations, supporting recent findings.
